An International Vision for Wheat Improvement
Friday, May 17, 2013
By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population.
Columbia Licenses Novel 3-D Organ and Tumor Segmentation Software to Varian Medical Systems
Friday, May 17, 2013
Allows for more precise and efficient planning and monitoring of cancer treatment.
Yale Cancer Center Carves New Path in Immunotherapy
Friday, May 17, 2013
Cancer immunotherapy is showing promise in treating patients with a variety of advanced, metastatic tumors.
UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Friday, May 17, 2013
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
App Helps Doctors, Students Learn to Diagnose Neurological Symptoms and Disease
Friday, May 17, 2013
The new app that presents a novel approach to learning the neurological physical exam, a challenging series of assessments aimed at diagnosing neurological disorders in patients.
Merck Serono and Quintiles Announce Innovative Clinical Development Partnership
Friday, May 17, 2013
Agreement creates unique strategic collaboration for development and clinical trial execution.
QPharma Appoints Chief Medical Officer
Friday, May 17, 2013
Dr. Shaw will oversee numerous initiatives, including QPharma’s QLaunch™ platform for maximizing the compliance and commercial effectiveness of life science product launches.
Biogen Idec Foundation Awards $250,000 to Develop Genetics Education Program
Friday, May 17, 2013
GenoExplorers seeks to introduce middle school students to genetics concepts through interactive learning.
TherapeuticsMD Elects Jules A. Musing to Board of Directors
Friday, May 17, 2013
TherapeuticsMD, Inc. announced the election of Jules A. Musing, a former senior executive at Johnson & Johnson, to its Board of Directors, effective immediately.
|
|
|
|
|
|
